Cognition Therapeutics (CGTX) Preferred Dividend Payments (2020 - 2021)
Cognition Therapeutics (CGTX) reported Preferred Dividend Payments of $1.9 million for Q3 2021, up 74.72% year-over-year from $1.1 million in Q3 2020, and up 74.72% on a QoQ basis from $1.1 million in Q3 2020.
Cognition Therapeutics (CGTX) has 2 years of Preferred Dividend Payments data on file, last reported at $1.9 million in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 1.86 Mn |
| Sep 30, 2020 | 1.06 Mn |